Thompson D G, Mason A S, Goodwin F J
Clin Endocrinol (Oxf). 1979 May;10(5):499-506. doi: 10.1111/j.1365-2265.1979.tb02107.x.
Eight patients with treated Addison's disease were studied whilst receiving different doses of fludrocortisone together with a constant intake of glucocorticoid. Plasma renin activity (PRA), blood pressure, pulse rate and plasma potassium and urea concentrations were measured after 2-week periods on each dose. In two patients, PRA measurements indicated that mineralocorticoid replacement therapy had been inadequate. In four others, PRA remained normal throughout the study, even after fludrocortisone had been discontinued, suggesting that the drug was unnecessary for the maintenance of normal sodium balance in these patients. Asymptomatic fludrocortisone overdosage was indicated by a low plasma potassium concentration, but not by PRA measurements which failed in this study to distinguish between adequate and excessive mineralocorticoid replacement.
对8例接受过治疗的艾迪生病患者进行了研究,他们在持续摄入糖皮质激素的同时接受不同剂量的氟氢可的松治疗。在每种剂量治疗2周后,测量血浆肾素活性(PRA)、血压、脉搏率以及血浆钾和尿素浓度。有2例患者的PRA测量结果表明盐皮质激素替代治疗不足。另外4例患者在整个研究过程中PRA均保持正常,即使在停用氟氢可的松后也是如此,这表明该药物对于维持这些患者的正常钠平衡并非必要。血浆钾浓度低表明存在无症状的氟氢可的松过量,但PRA测量结果未能区分盐皮质激素替代是否充足或过量,在本研究中PRA测量无法做到这一点。